![AbbVie and Eisai Announce the Launch of HUMIRA® Pen, an Auto-Injector Formulation for Fully Human Anti-TNF-α Monoclonal Antibody HUMIRA® | News Release:2018 | Eisai Co., Ltd. AbbVie and Eisai Announce the Launch of HUMIRA® Pen, an Auto-Injector Formulation for Fully Human Anti-TNF-α Monoclonal Antibody HUMIRA® | News Release:2018 | Eisai Co., Ltd.](https://www.eisai.com/news/2018/images/news201846-1.jpg)
AbbVie and Eisai Announce the Launch of HUMIRA® Pen, an Auto-Injector Formulation for Fully Human Anti-TNF-α Monoclonal Antibody HUMIRA® | News Release:2018 | Eisai Co., Ltd.
![Innovation Award nominée supporting patients in at-home treatment by patient-oriented interviews | Ramsay Santé EU Innovation Award nominée supporting patients in at-home treatment by patient-oriented interviews | Ramsay Santé EU](https://www.ramsaysante.eu/sites/default/files/styles/webp/public/2022-09/le%20stylo.png.webp?itok=pRO-2kfW)
Innovation Award nominée supporting patients in at-home treatment by patient-oriented interviews | Ramsay Santé EU
![Infliximab Stock Photo - Download Image Now - Ulcerative Colitis, Abstract, Ankylosing Spondylitis - iStock Infliximab Stock Photo - Download Image Now - Ulcerative Colitis, Abstract, Ankylosing Spondylitis - iStock](https://media.istockphoto.com/id/868766408/photo/infliximab.jpg?s=1024x1024&w=is&k=20&c=wSUohrxJVpw62bAS2dJLdWh21UDhQgqkdEonBdMPWyE=)